Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF

This publication has 56 references indexed in Scilit:

• An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
  Oncogene, 2000
• Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics Consortium
  Journal of Clinical Oncology, 1999
• Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
  The EMBO Journal, 1999
• The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
  The EMBO Journal, 1998
• Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
  Proceedings of the National Academy of Sciences, 1998
• ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways
  Published by Elsevier ,1998
• The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53
  Cell, 1998
• Cancer Cell Cycles
  Science, 1996
• Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
  Cell, 1995
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993